Pfizer, Inc. (NYSE:PFE).
Gateway Investment Advisers LLC says it lowered its ownership in Pfizer, Inc. stock by 2.0% as reported in a filing on 07/12/2017. Its stake stood at $106,661,000 a decrease of $4,233,000 according to the filing.
Here are a few other firms who have updated their positions. Pennsylvania Trust Co grew its investment by buying 174,867 shares an increase of 37.7%. Pennsylvania Trust Co owns 638,149 shares worth $21,444,000. The total value of its holdings increased 35.3%. Narwhal Capital Management added to its position by buying 20,025 shares an increase of 14.3% from 03/31/2017 to 06/30/2017. Narwhal Capital Management now holds 160,055 shares valued at $5,376,000. The value of the position overall is up by 12.2%.
Banced Corp downsized its stake by shedding 2,531 shares a decrease of 8.5% in the quarter. Banced Corp currently owns 27,357 shares with a value of $919,000. The value of the position overall is down by 10.1%.
On May 16 the company was downgraded to “Sell” from “Buy” in an announcement from Citigroup. Guggenheim added the stock to its research portfolio setting a rating of “Neutral”.
On November 29, 2016 the stock rating was changed to a “Overweight” according to a Barclays report which is up from the previous “Equal-weight” rating. On November 2 the company was set at “Market Perform” by Argus a cut from the previous “Outperform” rating.
On November 2 the stock rating was downgraded from “Outperform” to “Market Perform” in a report from BMO Capital. On October 13 the company was downgraded from “Buy” to “Hold” by Jefferies.
In the market the company is trading up by 0.66% since yesterday’s close of $33.17. Pfizer, Inc. also recently announced a dividend for shareholders that will be paid on Fri Sep 1, 2017. The dividend will be $0.320 per share for the quarter or $1.28 annualized. This dividend represents a yield of $3.84. The ex-dividend date is set for Wednesday the 10th of May 2017.
Shares of the company are trading at $33.39 a tad above the 50 day moving average of $32.80 and which is a tad above the 200 day moving average of $33.17. The 50 day moving average went up by +1.61% and the 200 day average was up $0.16.
The P/E ratio is currently 28.06 and the market cap is 198.91B. In the latest earnings report the EPS was $1.19 and is estimated to be $2.55 for the current year with 5,967,844,000 shares now outstanding. Next quarter’s EPS is expected be $0.64 with next year’s EPS projected to be $2.74.